Adjuvant therapy for node-negative breast cancer: The use of prognostic factors in selecting patients

This publication has 16 references indexed in Scilit:

• How To Use Prognostic Factors in Axillary Node-Negative Breast Cancer Patients
  JNCI Journal of the National Cancer Institute, 1990
• Cathepsin D and Prognosis in Breast Cancer
  New England Journal of Medicine, 1990
• Flow cytometry using paraffin‐embedded tissue: Five years on
  Cytometry, 1989
• Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow Cytometry
  New England Journal of Medicine, 1989
• A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.
  Journal of Clinical Oncology, 1989
• Efficacy of Adjuvant Chemotherapy in High-Risk Node-Negative Breast Cancer
  New England Journal of Medicine, 1989
• A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors
  New England Journal of Medicine, 1989
• Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
  Cancer, 1989
• Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06.
  Journal of Clinical Oncology, 1988
• Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
  Science, 1987